Arthritis and Rheumatic Disease Specialties

Recent papers from Arthritis and Rheumatic Disease Specialties

1. Vagus nerve-mediated neuroimmune modulation for rheumatoid arthritis: a pivotal randomized controlled trialNature Medicine · 2025
2. Neuroimmune Modulation for Drug-Refractory Rheumatoid Arthritis: Long-Term Safety and Efficacy in Patients Enrolled in a Pilot Vagus Nerve Stimulation StudyRheumatology and Therapy · 2025
3. Efficacy, Safety, and Immunogenicity of SDZ-ADL, an Adalimumab Biosimilar, in Biologic-Naïve and Switched Patients with Immune-Mediated Inflammatory Diseases: A Literature ReviewAdvances in Therapy · 2025
4. ‘Totality of Evidence’ Approach in the Development of GP2017, an Approved Adalimumab BiosimilarAdvances in Therapy · 2024
5. The results of a unique dietary supplement (nutraceutical formulation) used to treat the symptoms of long-haul COVIDFrontiers in Nutrition · 2022
6. Treatment with SDZ-ADL, an Adalimumab Biosimilar, in Patients with Rheumatoid Arthritis, Psoriasis, or Psoriatic Arthritis: Results of Patient-Reported Outcome Measures from Two Phase III Studies (ADMYRA and ADACCESS)BioDrugs · 2021
7. Switching to Biosimilar SDZ-ADL in Patients with Moderate-to-Severe Active Rheumatoid Arthritis: 48-Week Efficacy, Safety and Immunogenicity Results From the Phase III, Randomized, Double-Blind ADMYRA StudyBioDrugs · 2020
8. Factor VIII exhibits chaperone-dependent and glucose-regulated reversible amyloid formation in the endoplasmic reticulumBlood · 2020
9. Current and Future Management of Degenerative Spine DiseasesJapanese Journal of Neurosurgery · 2020
10. Patient Perspectives on Intravenous Biologics for Rheumatologic DiseaseArthritis Care & Research · 2018
11. Methotrexate Dosage Reduction Upon Adalimumab Initiation: Clinical and Ultrasonographic Outcomes from the Randomized Noninferiority MUSICA TrialThe Journal of Rheumatology · 2016
12. Correlation Between Residual Displacement and Osteonecrosis of the Femoral Head Following Cannulated Screw Fixation of Femoral Neck FracturesMedicine · 2015
13. Golimumab in patients with active rheumatoid arthritis after treatment with tumor necrosis factor α inhibitors: findings with up to five years of treatment in the multicenter, randomized, double-blind, placebo-controlled, phase 3 GO-AFTER studyArthritis Research & Therapy · 2015
14. Safety of infusing rituximab at a more rapid rate in patients with rheumatoid arthritis: results from the RATE-RA studyBMC Musculoskeletal Disorders · 2014
15. Musculoskeletal Ultrasound Training and Competency Assessment Program for Rheumatology FellowsJournal of Ultrasound in Medicine · 2013
16. The effect of golimumab on haemoglobin levels in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitisLara D. Veeken · 2013
17. Monitoring cartilage loss in the hands and wrists in rheumatoid arthritis with magnetic resonance imaging in a multi-center clinical trial: IMPRESS (NCT00425932)Arthritis Research & Therapy · 2013
18. Evaluating joint-space narrowing and cartilage loss in rheumatoid arthritis by using MRIArthritis Research & Therapy · 2012
19. Long-Term Follow-Up of an HIV-Infected Patient With Reactive Arthritis Treated With InfliximabJCR Journal of Clinical Rheumatology · 2012
20. Golimumab in patients with active rheumatoid arthritis who have previous experience with tumour necrosis factor inhibitors: results of a long-term extension of the randomised, double-blind, placebo-controlled GO-AFTER study through week 160Annals of the Rheumatic Diseases · 2012